AN ACT INCREASING THE BOND AUTHORIZATION FOR THE CONNECTICUT BIOSCIENCE INNOVATION FUND.
Connecticut increases state bond authorization for bioscience innovation fund to boost biotech investment and economic development capacity.
Connecticut increases state bond authorization for bioscience innovation fund to boost biotech investment and economic development capacity.
SB 31 authorizes increased bonding (borrowing) for Connecticut's Bioscience Innovation Fund, a state program designed to support research, development, and commercialization of bioscience ventures. The bill expands the state's financial capacity to invest in biotech companies and research initiatives within Connecticut. The specific dollar amount of the increase is not detailed in the action history provided.
Bioscience and biotechnology are high-growth industries with significant potential for job creation and economic development. Connecticut's bonding authorization directly affects how much capital the state can deploy to attract and nurture biotech companies, potentially influencing the state's competitiveness in this sector. These investments can drive innovation, attract talent, and generate tax revenue, though they also represent public debt obligations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.